EIF3B and lung carcinoma: Two lung cancer-associated mutations in eIF3b and eIF3c that have been tested in course of this study also had the capacity to reverse the reduced size phenotype, indicating that both mutations do not represent loss-of-function mutants of the eIF3-complex.